To actualize the aspiration of personalized interscreening intervals informed by f-Hb measurements, we aimed to comprehensively assess the association of f-Hb levels with the risk of adenoma, incident CRC, advanced CRC manifestations, and CRC-associated mortality. This evidence concerns the gene GSTM1 and colorectal carcinoma.